Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

13.4K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
13.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of early antiretroviral treatment on tissue resident memory CD4+ T cells in the gastrointestinal tract.

The Journal of infectious diseases·2026
Same author

A psychometric assessment of the Patient Health Questionnaire-9 for people living with acutely-treated HIV in Thailand.

Psychiatry research communications·2026
Same author

Long-Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection.

Annals of clinical and translational neurology·2026
Same author

Consideration of brain health in ART interruption studies - Authors' reply.

The lancet. HIV·2026
Same author

Rapid and profound decay of inducible and intact HIV genomes in early-treated Thai children.

The Journal of clinical investigation·2026
Same author

Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials.

The lancet. HIV·2026

Related Experiment Video

Updated: May 4, 2026

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity
10:14

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity

Published on: December 17, 2013

18.0K

Cell-based flow cytometry assay to measure cytotoxic activity.

Alessandra Noto1, Pearline Ngauv1, Lydie Trautmann2

  • 1Vaccine and Gene Therapy Institute of Florida.

Journal of Visualized Experiments : Jove
|January 1, 2014
PubMed
Summary

We developed a new assay to measure CD8+ T cell killing of CD4+ T cells. This method accurately quantifies the cytotoxic capacity of antigen-specific CD8+ T cells.

More Related Videos

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

24.2K
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

14.8K

Related Experiment Videos

Last Updated: May 4, 2026

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity
10:14

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity

Published on: December 17, 2013

18.0K
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

24.2K
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

14.8K

Area of Science:

  • Immunology
  • Cellular immunology
  • T cell biology

Background:

  • Cytolytic activity of CD8+ T cells is crucial for immune responses but rarely evaluated.
  • Existing methods for assessing CD8+ T cell cytotoxicity are often complex or indirect.

Purpose of the Study:

  • To describe a novel, simple, and accurate cell-based assay for measuring the killing capacity of antigen-specific CD8+ T cells against target CD4+ T cells.
  • To enable the quantification of intrinsic CD8+ T cell cytotoxic potential.

Main Methods:

  • Target CD4+ T cells were labeled with different concentrations of CFSE, with one population pulsed with cognate peptide (CFSE-low) and the other un-pulsed (CFSE-high).
  • Pulsed and un-pulsed target cells were mixed and co-cultured with increasing numbers of purified CD8+ T cells.
  • Specific killing was analyzed by flow cytometry, identifying antigen-specific CD8+ T cells using peptide/MHCI tetramer staining.

Main Results:

  • The assay allows for the analysis of specific lysis of target CD4+ T cells at various effector-to-target ratios.
  • The calculation of lytic units (LU₃₀/10⁶ cells) provides a quantitative measure of CD8+ T cell killing capacity.
  • Demonstrated accurate measurement of the intrinsic cytotoxic potential of CD8+ T cells.

Conclusions:

  • The described assay is a simple and straightforward method for evaluating CD8+ T cell-mediated cytotoxicity.
  • This assay facilitates the accurate measurement of the intrinsic capacity of CD8+ T cells to kill target CD4+ T cells.
  • Provides a valuable tool for immunological research and clinical applications involving T cell function.